Regulating PMP22 expression as a dosage sensitive neuropathy gene
- 3 October 2019
- journal article
- review article
- Published by Elsevier BV in Brain Research
- Vol. 1726, 146491
- https://doi.org/10.1016/j.brainres.2019.146491
Abstract
No abstract availableKeywords
Funding Information
- Charcot-Marie-Tooth Association
- NINDS/NIH (1R01NS083841)
This publication has 94 references indexed in Scilit:
- c-Jun Reprograms Schwann Cells of Injured Nerves to Generate a Repair Cell Essential for RegenerationNeuron, 2012
- Genome-wide analysis of EGR2/SOX10 binding in myelinating peripheral nerveNucleic Acids Research, 2012
- Distal enhancers upstream of the Charcot-Marie-Tooth type 1A disease gene PMP22Human Molecular Genetics, 2011
- Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trialThe Lancet Neurology, 2011
- Mechanisms for Nonrecurrent Genomic Rearrangements Associated with CMT1A or HNPP: Rare CNVs as a Cause for Missing HeritabilityAmerican Journal of Human Genetics, 2010
- The Hippo–YAP pathway in organ size control and tumorigenesis: an updated versionGenes & Development, 2010
- Copy number variation upstream of PMP22 in Charcot–Marie–Tooth diseaseEuropean Journal of Human Genetics, 2009
- P2X7-mediated Increased Intracellular Calcium Causes Functional Derangement in Schwann Cells from Rats with CMT1A NeuropathyOnline Journal of Public Health Informatics, 2009
- PMP22 expression in dermal nerve myelin from patients with CMT1ABrain, 2009
- Peripheral myelin protein 22 is regulated post‐transcriptionally by miRNA‐29aGlia, 2009